Medicare Drug Price Negotiation Program

Regulatory Issues June 22, 2026

CMS Proposed Rule Locks in Lower Prices

Fosters Innovation for the Medicare Drug Price Negotiation Program – A new proposal from the CMS would establish a permanent framework for the Medicare Drug Price Negotiation Program, creating a more transparent and sustainable process for lowering drug costs for millions of Medicare beneficiaries.

News July 28, 2023

Revised Guidance for Historic Medicare Drug Price Negotiation Program

For the first time in history, Medicare has the ability to directly negotiate the prices of covered prescription drugs due to President Biden’s historic prescription drug law, the Inflation Reduction Act.